Help them: Keep ON time Keep on their current treatment
Help them: Keep ON time Keep on their current treatment
Not actual patients.
The limitations of levodopa2,3
Inconsistent levodopa response increases the need for adjunctive treatment options
Not actual patients.
Inconsistent levodopa response increases the need for adjunctive treatment options
IMPORTANT SAFETY INFORMATION FOR HEALTHCARE PROVIDERS
CONTRAINDICATIONS
WARNINGS & PRECAUTIONS
DOSING GUIDELINES & CONSIDERATIONS
ADVERSE REACTIONS
INDICATION
Please see full Prescribing Information and Patient Information.
To report SUSPECTED ADVERSE REACTIONS or product complaints, contact Supernus Pharmaceuticals, Inc. at 1-888-492-3246 (1-888-4XADAGO). You may also report SUSPECTED ADVERSE REACTIONS to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
References
1. XADAGO. Package Insert. US WorldMeds, LLC. 2. Hickey P, Stacy M. Available and emerging treatments for Parkinson’s disease: a review. Drug Des Devel Ther. 2011:241-254. 3. Jankovic J. Motor fluctuations and dyskinesias in Parkinson’s disease: clinical manifestations. Mov Disord. 2005;20(11):S11-S16.
IMPORTANT SAFETY INFORMATION FOR HEALTHCARE PROVIDERS
CONTRAINDICATIONS
WARNINGS & PRECAUTIONS
DOSING GUIDELINES & CONSIDERATIONS
ADVERSE REACTIONS
INDICATION
Please see full Prescribing Information and Patient Information.
To report SUSPECTED ADVERSE REACTIONS or product complaints, contact Supernus Pharmaceuticals, Inc. at 1-888-492-3246 (1-888-4XADAGO). You may also report SUSPECTED ADVERSE REACTIONS to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.